Tags

Type your tag names separated by a space and hit enter

IL-12p40 is essential for the down-regulation of airway hyperresponsiveness in a mouse model of bronchial asthma with prolonged antigen exposure.
Clin Exp Allergy. 2009 Feb; 39(2):290-8.CE

Abstract

BACKGROUND

We previously reported a mouse model of bronchial asthma showing eosinophilic inflammation, but not airway hyperresponsiveness (AHR), after prolonged antigen exposure. This model showed an increase of IL-12 in the lung.

OBJECTIVE

The aim of this study was to investigate the role of IL-12p40 in a murine asthma model with prolonged antigen exposures.

METHODS

An ovalbumin (OVA)-induced asthma model was first established in wild-type (WT) and IL-12p40-deficient (IL-12p40(-/-)) mice. Both strains of mice were further exposed to either OVA (prolonged exposure group) or phosphate-buffered saline (positive control group) 3 days per week for 3 weeks. During week 4, both groups of mice were given a final challenge with OVA.

RESULTS

Prolonged antigen exposures resulted in marked suppression of airway eosinophilia in both WT and IL-12p40(-/-) mice. However, AHR persisted in IL-12p40(-/-) but not in WT mice. There were no significant differences of IL-5, IL-13 or IFN-gamma levels in bronchoalveolar lavage fluid between WT and IL-12p40(-/-) mice. The hydroxyproline content of the lung and peribronchial fibrosis were, however, significantly increased in IL-12p40(-/-) mice.

CONCLUSION

The results suggest that endogenous IL-12p40 is essential for inhibition of AHR and peribronchial fibrosis, but not eosinophilic inflammation, in a murine asthma model with prolonged antigen exposures.

Authors+Show Affiliations

Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19032358

Citation

Onari, Y, et al. "IL-12p40 Is Essential for the Down-regulation of Airway Hyperresponsiveness in a Mouse Model of Bronchial Asthma With Prolonged Antigen Exposure." Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology, vol. 39, no. 2, 2009, pp. 290-8.
Onari Y, Yokoyama A, Haruta Y, et al. IL-12p40 is essential for the down-regulation of airway hyperresponsiveness in a mouse model of bronchial asthma with prolonged antigen exposure. Clin Exp Allergy. 2009;39(2):290-8.
Onari, Y., Yokoyama, A., Haruta, Y., Nakashima, T., Iwamoto, H., Hattori, N., & Kohno, N. (2009). IL-12p40 is essential for the down-regulation of airway hyperresponsiveness in a mouse model of bronchial asthma with prolonged antigen exposure. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology, 39(2), 290-8. https://doi.org/10.1111/j.1365-2222.2008.03131.x
Onari Y, et al. IL-12p40 Is Essential for the Down-regulation of Airway Hyperresponsiveness in a Mouse Model of Bronchial Asthma With Prolonged Antigen Exposure. Clin Exp Allergy. 2009;39(2):290-8. PubMed PMID: 19032358.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - IL-12p40 is essential for the down-regulation of airway hyperresponsiveness in a mouse model of bronchial asthma with prolonged antigen exposure. AU - Onari,Y, AU - Yokoyama,A, AU - Haruta,Y, AU - Nakashima,T, AU - Iwamoto,H, AU - Hattori,N, AU - Kohno,N, Y1 - 2008/11/17/ PY - 2008/11/27/pubmed PY - 2009/3/31/medline PY - 2008/11/27/entrez SP - 290 EP - 8 JF - Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology JO - Clin Exp Allergy VL - 39 IS - 2 N2 - BACKGROUND: We previously reported a mouse model of bronchial asthma showing eosinophilic inflammation, but not airway hyperresponsiveness (AHR), after prolonged antigen exposure. This model showed an increase of IL-12 in the lung. OBJECTIVE: The aim of this study was to investigate the role of IL-12p40 in a murine asthma model with prolonged antigen exposures. METHODS: An ovalbumin (OVA)-induced asthma model was first established in wild-type (WT) and IL-12p40-deficient (IL-12p40(-/-)) mice. Both strains of mice were further exposed to either OVA (prolonged exposure group) or phosphate-buffered saline (positive control group) 3 days per week for 3 weeks. During week 4, both groups of mice were given a final challenge with OVA. RESULTS: Prolonged antigen exposures resulted in marked suppression of airway eosinophilia in both WT and IL-12p40(-/-) mice. However, AHR persisted in IL-12p40(-/-) but not in WT mice. There were no significant differences of IL-5, IL-13 or IFN-gamma levels in bronchoalveolar lavage fluid between WT and IL-12p40(-/-) mice. The hydroxyproline content of the lung and peribronchial fibrosis were, however, significantly increased in IL-12p40(-/-) mice. CONCLUSION: The results suggest that endogenous IL-12p40 is essential for inhibition of AHR and peribronchial fibrosis, but not eosinophilic inflammation, in a murine asthma model with prolonged antigen exposures. SN - 1365-2222 UR - https://www.unboundmedicine.com/medline/citation/19032358/IL_12p40_is_essential_for_the_down_regulation_of_airway_hyperresponsiveness_in_a_mouse_model_of_bronchial_asthma_with_prolonged_antigen_exposure_ DB - PRIME DP - Unbound Medicine ER -